Pharma

Women’s Health Pharma Company Organon Launches Its First Awareness Campaign Tackling Unplanned Pregnancy

Bayer starts Phase III Development with an Investigative Non-hormonal Treatment Option for Vasomotor Symptoms during Menopause

Bayer’s Mirena IUD Gets FDA Approval for Pregnancy Prevention for Up to 7 Years

Roche Withdraws Tecentriq, a Drug for Metastatic Triple-Negative Breast Cancer, in the U.S.

TherapeuticsMD Receives a J-Code for its Long-Lasting, Patient-Controlled Contraceptive ANNOVERA

Premier Research Acquires Specialty Women’s Health and Diagnostics Clinical Research Organization Health Decisions

Organon and ObsEva Enter Global License Agreement for Preterm Labor Treatment

Jeeva Wants to Help Increase Patient Diversity in Clinical Trials

Women’s Health Pharma Company Theramex Appoints Sigurd Kirk to its Board of Directors

Medicines360, a Global Nonprofit Women’s Health Pharmaceutical Organization, Appoints Dr. Tina Raine-Bennett as Chief Executive Officer

Lupin Announces FDA Approval of Supplemental New Drug Application for SOLOSEC for the Treatment of Trichomoniasis

Women of Color in Pharma Launch “We Are Pharma!”, an Initiative to address COVID-19 Vaccination Concerns in Minority Communities

#NoApologiesPeriod: Bayer’s Period Pain Relief Brand Midol Launches a New Campaign Encouraging Period Positivity

Auransa and POLARISqb Enter Research Collaboration to Find Treatments for Neglected Women’s Diseases Like Endometriosis and PCOS

Merck Spin-off Organon Launches as a New Global Women’s Health Company

SCYNEXIS Receives FDA Approval for BREXAFEMME, the First and Only Oral Non-Azole Treatment for Vaginal Yeast Infections

Myovant and Pfizer Receive FDA Approval for MYFEMBREE, the First Once-Daily Treatment for Heavy Menstrual Bleeding Associated With Uterine Fibroids

Dr. Stephen Palmer Joins the Celmatix Executive Team to Lead the Company’s Drug Discovery and Development Efforts in Ovarian Health as Chief Scientific Officer

Biovaxys Adds Charles J. Dunton, MD as Scientific Advisor to Support the Company’s Ovarian Cancer Vaccine Clinical Program and Papilocare Marketing

Evofem Receives Fast Track Designation for EVO100 for Prevention of Gonorrhea in Women

Women’s Reproductive Health Pharma Company ObsEva Appoints Clive Bertram as Chief Commercial Officer

Menopause: TherapeuticsMD Launches a Bold, New Campaign Promoting Imvexxy, Its Estrogen Softgel Insert That Treats Vaginal Dryness